Depot Naltrexone Treatment of Opioid Dependent Parolees

Not Applicable

Completed

• Conditions: Opioid Dependence
• Interventions: Drug: Depot Naltrexone

• Registration Number: NCT00756990
• Lead Sponsor: University of Pennsylvania

Brief Summary

This is an investigation involving the use of a long-acting, injectable form (depot) of naltrexone as a treatment for persons who have a history of opioid dependence, with up to 40 on parole/probation and 20 non-parolees. The test is a pilot study of up to 60 subjects treated with 6 months of depot naltrexone plus Psychosocial Treatment .

Detailed Description

This is a two phase study. Phase 1 is complete and phase 2 is not yet recruiting.

Study Timeline

• Study Start: 2005-11
• Study First Submitted: 2008-09-19
• Study First Submitted QC: 2008-09-19
• Study First Posted: 2008-09-22
• Primary Completion: 2009-03
• Study Completion: 2011-08
• Status Verified: 2019-04
• Last Update Submitted: 2019-04-19
• Last Update Posted: 2019-04-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 61

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Single group	Depot Naltrexone	Depot Naltrexone

Primary Outcome Measures

Name	Time	Method
UDS results	6 months

Secondary Outcome Measures

Name	Time	Method
Treatment completion	6 months

Trial Locations

Locations (1)

University of Pennsylvania; 🇺🇸 Philadelphia, Pennsylvania, United States